MedPath

Evaluation of clinical and radiographic success and failure of MTA and Biodentine in pulp therapy of mandibular primary molar with reversible pulpitis

Phase 3
Conditions
Irreversible pulpitis of mandibular primary molar.
Pulpitis
K04.0
Registration Number
IRCT20230718058836N1
Lead Sponsor
Ilam University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
58
Inclusion Criteria

Initial inclusion criteria include patients who do not have any systemic diseases such as congenital or rheumatic heart disease, leukemia, allergic reactions to substances such as local anesthetics and latex, do not need general anesthesia and sedation, have good individual and family cooperation, Deep cavity lesions whose pulp is exposed during caries removal and are vital, no history of spontaneous or nocturnal pain; Absence of clinical signs such as swelling, fistula, sensitivity to precussion or palpation, pathological mobility; teeth in which hemostasis is achieved within 5 minutes during the clinical procedure; The presence of two-thirds of the root length radiographically; and lack of radiographic evidence of pulp degeneration, such as internal or external root resorption, furca radiolucency, intraradicular or periapical bone destruction, pulp stones.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath